Compare MDGL & FUTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDGL | FUTU |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 12.6B |
| IPO Year | 2005 | 2018 |
| Metric | MDGL | FUTU |
|---|---|---|
| Price | $476.16 | $94.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $674.45 | $217.75 |
| AVG Volume (30 Days) | 255.0K | ★ 5.7M |
| Earning Date | 05-06-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 3.39% |
| EPS Growth | ★ 41.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.39 | $27.96 |
| Revenue Next Year | $48.55 | $11.89 |
| P/E Ratio | ★ N/A | $17.05 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $275.00 | $80.50 |
| 52 Week High | $615.00 | $202.53 |
| Indicator | MDGL | FUTU |
|---|---|---|
| Relative Strength Index (RSI) | 41.84 | 32.25 |
| Support Level | $456.39 | $80.50 |
| Resistance Level | $502.97 | $172.56 |
| Average True Range (ATR) | 19.13 | 7.07 |
| MACD | -3.10 | -0.12 |
| Stochastic Oscillator | 34.03 | 37.75 |
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Futu Holdings Ltd is an online broker providing one-stop online investing services.. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Group engages in online brokerage services and margin financing services. It generates its revenue in the form of brokerage commission and handling charge services, and interest income. Geographically, it operates in Hong Kong, which derives key revenue and it also has its presence in other countries.